CALR mutations are a revolutionary discovery and represent an important hallmark of
myeloproliferative neoplasms (MPN), especially essential thrombocythemia and primary …

Suspicion of myeloproliferative neoplasms (MPNs) and especially essential
thrombocythemia (ET) in primary care is often based solely on blood counts, with patients …

Objective: In this study, we investigated the effects of calreticulin (CALR) and JAK2V617F
mutational status on clinical course and disease outcomes in Turkish patients with essential …

Essential thrombocythemia (ET) is characterized by thrombotic and hemorrhagic events. The
association of clinical characteristics of Chinese ET patients and additional sex combs like 1 …

Essential thrombocythemia (ET) with double driver mutations is a rare disease. ET patients
with both MPL and Type 1 CALR mutations have been reported. Here, we report the first …

BACKGROUND: Myeloproliferative neoplasms (MPNs) without Break Point Cluster-Abelson
(BCR-ABL) are mainly divided into three major types: polycythemia vera, essential …

Patients with myeloproliferative neoplasm (MPNs) present at the onset or during evolution
thrombotic complications. The microvascular inflammatory and thrombotic complications in …

Essential thrombocythemia (ET) is a clonal bone marrow stem cell disorder, primarily
involving the megakaryocytic lineage. The WHO 2016 guidelines include the molecular …

Objective: To determine the frequency of JAK2V617F mutation in Thai patients with clinically
suspected myeloproliferative neoplasms [MPNs] including polycythemia vera [PV], essential …

Za pomoč pri izdelavi doktorske naloge se iskreno zahvaljujem Kliničnemu oddelku za
hematologijo UKC Ljubljana ter vsem zaposlenim v Specializiranem hematološkem …